KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.63M | 17.97M | 17.84M | 17.51M | 18.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.41M | 41.64M | 40.55M | 39.31M | 40.43M |
| Operating Income | -42.41M | -41.64M | -40.55M | -39.31M | -40.43M |
| Income Before Tax | -26.98M | -35.84M | -37.23M | -35.65M | -38.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.98 | -35.84 | -37.23 | -35.65 | -38.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.98M | -35.84M | -37.23M | -35.65M | -38.51M |
| EBIT | -42.41M | -41.64M | -40.55M | -39.31M | -40.43M |
| EBITDA | -42.09M | -41.31M | -40.28M | -39.05M | -40.18M |
| EPS Basic | -207.13 | -296.90 | -339.90 | -412.32 | -551.68 |
| Normalized Basic EPS | -165.10 | -199.91 | -208.76 | -255.06 | -340.51 |
| EPS Diluted | -207.13 | -296.90 | -339.90 | -412.32 | -551.68 |
| Normalized Diluted EPS | -165.10 | -199.91 | -208.76 | -255.06 | -340.51 |
| Average Basic Shares Outstanding | 651.70K | 491.90K | 443.70K | 374.00K | 303.40K |
| Average Diluted Shares Outstanding | 651.70K | 491.90K | 443.70K | 374.00K | 303.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |